Pharmacokinetics in pregnancy

被引:136
作者
Dawes, M [1 ]
Chowienczyk, PJ [1 ]
机构
[1] St Thomas Hosp, Dept Clin Pharmacol, London SE1 7EH, England
来源
BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY | 2001年 / 15卷 / 06期
关键词
pharmacokinetics; half-life; clearance; dose; bioavailability; distribution;
D O I
10.1053/beog.2001.0231
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Pharmacokinetics describes the handling of a drug by the body - how the drug is absorbed, distributed and eliminated and how these processes determine plasma concentrations of the drug. Changes in maternal physiology during pregnancy influence pharmacokinetics, and this may have important sequelae for drug dosing, especially for drugs for which adverse effects occur at concentrations within, or just above, the therapeutic range. For many drugs absorption is decreased and elimination increased, thus tending to reduce plasma concentrations. There are, however, relatively few specific data on pharmacokinetics in pregnancy, compared to the non-gravid state, because of the obvious ethical issues surrounding studies during pregnancy. Most therapeutic guidelines are thus based on observational studies and basic principles.
引用
收藏
页码:819 / 826
页数:8
相关论文
共 16 条
[1]   NIFEDIPINE PHARMACOKINETICS AND PHARMACODYNAMICS DURING THE IMMEDIATE POSTPARTUM PERIOD IN PATIENTS WITH PREECLAMPSIA [J].
BARTON, JR ;
PREVOST, RR ;
WILSON, DA ;
WHYBREW, WD ;
SIBAI, BM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (04) :951-954
[2]   PHARMACOKINETICS AND PROTEIN-BINDING OF CEFTRIAXONE DURING PREGNANCY [J].
BOURGET, P ;
FERNANDEZ, H ;
QUINQUIS, V ;
DELOUIS, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (01) :54-59
[3]   PHARMACOKINETICS OF AMPICILLIN AND SULBACTAM IN PREGNANCY [J].
CHAMBERLAIN, A ;
WHITE, S ;
BAWDON, R ;
THOMAS, S ;
LARSEN, B .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (02) :667-673
[4]   ANTIEPILEPTIC DRUGS - METABOLISM IN PREGNANCY [J].
DAM, M ;
CHRISTIANSEN, J ;
MUNCK, O ;
MYGIND, KI .
CLINICAL PHARMACOKINETICS, 1979, 4 (01) :53-62
[5]   MEPERIDINE DISPOSITION IN MOTHER, NEONATE, AND NON-PREGNANT FEMALES [J].
KUHNERT, BR ;
KUHNERT, PM ;
PROCHASKA, AL ;
SOKOL, RJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) :486-491
[6]   Pharmacokinetics during pregnancy: Evidence-based maternal dose formulation [J].
Little, BB .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (05) :858-868
[7]   Pharmacokinetic changes during pregnancy and their clinical relevance [J].
Loebstein, R ;
Lalkin, A ;
Koren, G .
CLINICAL PHARMACOKINETICS, 1997, 33 (05) :328-343
[8]   PARACETAMOL METABOLISM IN PREGNANCY [J].
MINERS, JO ;
ROBSON, RA ;
BIRKETT, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (03) :359-362
[9]   PHARMACOKINETICS OF ANTIBIOTICS IN PREGNANCY AND LABOR [J].
PHILIPSON, A .
CLINICAL PHARMACOKINETICS, 1979, 4 (04) :297-309
[10]   PHARMACOKINETICS OF CEFUROXIME IN PREGNANCY [J].
PHILIPSON, A ;
STIERNSTEDT, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 142 (07) :823-828